Bio-Rad Laboratories

About

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

When was Bio-Rad Laboratories established in Israel and what was its initial function?

Bio-Rad Laboratories was established in Israel in 1991 as a sales branch.

What significant event occurred in 2006 for Bio-Rad Laboratories in Israel?

In 2006, Bio-Rad Laboratories acquired ProteOptics Ltd, a developer of surface plasmon resonance technology, which led to the opening of a research and development center renamed Bio-Rad Haifa.

What are the primary R&D activities of Bio-Rad Haifa?

Bio-Rad Haifa's R&D activities include the development of reagents and kits, as well as the design and engineering of analytical devices and instrumentations, serving the scientific, biotech, and pharma communities.

When did Bio-Rad Laboratories go public and on which exchange?

Bio-Rad Laboratories went public on the NYSE in February 1980.

What is the current market capitalization of Bio-Rad Laboratories?

As of January 1, 2026, Bio-Rad Laboratories has a market capitalization of $6,637,419,833 USD.

How many employees does Bio-Rad Laboratories have worldwide?

Bio-Rad Laboratories has 9,179 employees worldwide.

What is the primary sector of Bio-Rad Laboratories?

Bio-Rad Laboratories operates in Medical Devices and Equipment and Supplies.

What is the most recent news item regarding Bio-Rad Laboratories, according to startupim data?

On April 7, 2026, 247wallst.com published an article titled "Here Are Tuesday’s Top Wall Street Analyst Research Calls: Ameriprise Financial, Arista Networks, Arm Holdings, Lennar, Morgan Stanley, Rocket Lab, Tractor Supply, Wingstop, Wix.com and More," which included Bio-Rad Laboratories.

Tags